Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

532 ARTÍCULOS , VIENDO DEL 76 AL 90

Biological Signatures of Alzheimer's Disease

Sharma P, Sharma A, Fayaz F, Wakode S, Pottoo FH.

Curr Top Med Chem. 2020;20(9):770-781. doi: 10.2174/1568026620666200228095553.

Overview of cannabidiol (CBD) and its analogues: Structures, biological activities, and neuroprotective mechanisms in epilepsy and Alzheimer's disease

Li H, Liu Y, Tian D, Tian L, Ju X, Qi L, Wang Y, Liang C.

Eur J Med Chem. 2020 Apr 15;192:112163. doi: 10.1016/j.ejmech.2020.112163. Epub 2020 Feb 22.

Is There a Future for PPARs in the Treatment of Neuropsychiatric Disorders?

Tufano M, Pinna G.

Molecules. 2020 Feb 27;25(5):1062. doi: 10.3390/molecules25051062.

Learning from the Past: A Review of Clinical Trials Targeting Amyloid, Tau and Neuroinflammation in Alzheimer's Disease

Ceyzériat K, Zilli T, Millet P, Frisoni GB, Garibotto V, Tournier BB.

Curr Alzheimer Res. 2020;17(2):112-125. doi: 10.2174/1567205017666200304085513.

Aβ-ganglioside interactions in the pathogenesis of Alzheimer's disease

Matsuzaki K.

Biochim Biophys Acta Biomembr. 2020 Aug 1;1862(8):183233. doi: 10.1016/j.bbamem.2020.183233. Epub 2020 Mar 3.

Drug Repositioning for Alzheimer's Disease: Finding Hidden Clues in Old Drugs

Ihara M, Saito S.

J Alzheimers Dis. 2020;74(4):1013-1028. doi: 10.3233/JAD-200049.

Contribution of the Presenilins in the cell biology, structure and function of γ-secretase

Escamilla-Ayala A, Wouters R, Sannerud R, Annaert W.

Semin Cell Dev Biol. 2020 Sep;105:12-26. doi: 10.1016/j.semcdb.2020.02.005. Epub 2020 Mar 4.

The Bewildering Effect of AMPK Activators in Alzheimer's Disease: Review of the Current Evidence

Assefa BT, Tafere GG, Wondafrash DZ, Gidey MT.

Biomed Res Int. 2020 Feb 18;2020:9895121. doi: 10.1155/2020/9895121. eCollection 2020.

TV 3326 for Alzheimer's dementia: a novel multimodal ChE and MAO inhibitors to mitigate Alzheimer's-like neuropathology

Uddin MS, Kabir MT, Rahman MM, Mathew B, Shah MA, Ashraf GM.

J Pharm Pharmacol. 2020 Aug;72(8):1001-1012. doi: 10.1111/jphp.13244. Epub 2020 Mar 9.

Do infections have a role in the pathogenesis of Alzheimer disease?

Itzhaki RF, Golde TE, Heneka MT, Readhead B.

Nat Rev Neurol. 2020 Apr;16(4):193-197. doi: 10.1038/s41582-020-0323-9. Epub 2020 Mar 9.

Acetylcholinesterase: The "Hub" for Neurodegenerative Diseases and Chemical Weapons Convention

Cavalcante SFA, Simas ABC, Barcellos MC, de Oliveira VGM, Sousa RB, Cabral PAM, Kuča K, França TCC.

Biomolecules. 2020 Mar 7;10(3):414. doi: 10.3390/biom10030414.

Exploring the Promise of Targeting Ubiquitin-Proteasome System to Combat Alzheimer's Disease

Al Mamun A, Uddin MS, Kabir MT, Khanum S, Sarwar MS, Mathew B, Rauf A, Ahmed M, Ashraf GM.

Neurotox Res. 2020 Jun;38(1):8-17. doi: 10.1007/s12640-020-00185-1. Epub 2020 Mar 9.

Donepezil for dementia due to Alzheimer's disease

Govind N.

Br J Community Nurs. 2020 Mar 2;25(3):148-149. doi: 10.12968/bjcn.2020.25.3.148.

Nanoparticlized System: Promising Approach for the Management of Alzheimer's Disease through Intranasal Delivery

Bahadur S, Sachan N, Harwansh RK, Deshmukh R.

Curr Pharm Des. 2020;26(12):1331-1344. doi: 10.2174/1381612826666200311131658.

Research Progress on Alzheimer's Disease and Resveratrol

Yan Y, Yang H, Xie Y, Ding Y, Kong D, Yu H.

Neurochem Res. 2020 May;45(5):989-1006. doi: 10.1007/s11064-020-03007-0. Epub 2020 Mar 11.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias